Sep 3, 2020 11:39 am EDT Emerald Bioscience to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Aug 13, 2020 8:30 am EDT Emerald Bioscience Appoints Biotech Veteran Dr. Margaret Dalesandro to Board of Directors
Aug 4, 2020 6:32 pm EDT Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
Jul 31, 2020 9:20 am EDT Emerald Bioscience Announces Pricing of $7.0 Million Upsized Registered Offering
Jun 9, 2020 9:37 am EDT Emerald Bioscience Announces Presentation of Cannabidiol-Valine-Hemisuccinate Ocular Data at Virtual ARVO® Meeting
Jun 2, 2020 8:30 am EDT Emerald Bioscience Announces Awarding of Patent for Cannabidiol-Valine-Hemisuccinate in Japan
Mar 9, 2020 8:30 am EDT Emerald Bioscience Announces Notice of Allowance from United States Patent Office for Proprietary Analog of Cannabidiol